Xin Tang1,2, Tong Pang1, Wei-Feng Yan1, Wen-Lei Qian1, You-Ling Gong2, Zhi-Gang Yang1. 1. Department of Radiology, West China Hospital, Sichuan University, Chengdu, China. 2. Department of Thoracic Oncology and State Key Laboratory of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Abstract
BACKGROUND AND PURPOSE: Radiomics is an emerging field of quantitative imaging. The prognostic value of radiomics analysis in patients with localized clear cell renal cell carcinoma (ccRCC) after nephrectomy remains unknown. METHODS: Computed tomography images of 167 eligible cases were obtained from the Cancer Imaging Archive database. Radiomics features were extracted from the region of interest contoured manually for each patient. Hierarchical clustering was performed to divide patients into distinct groups. Prognostic assessments were performed by Kaplan-Meier curves, COX regression, and least absolute shrinkage and selection operator COX regression. Besides, transcriptome mRNA data were also included in the prognostic analyses. Endpoints were overall survival (OS) and disease-free survival (DFS). Concordance index (C-index), decision curve analysis and calibration curves with 1,000 bootstrapping replications were used for model's validation. RESULTS: Hierarchical clustering groups from nephrographic features and mRNA can divide patients into different prognostic groups while clustering groups from corticomedullary or unenhanced phase couldn't distinguish patients' prognosis. In multivariate analyses, 11 OS-predicting and eight DFS-predicting features were identified in nephrographic phase. Similarly, seven OS-predictors and seven DFS-predictors were confirmed in mRNA data. In contrast, limited prognostic features were found in corticomedullary (two OS-predictor and two DFS-predictors) and unenhanced phase (one OS-predictors and two DFS-predictors). Prognostic models combining both nephrographic features and mRNA showed improved C-index than any model alone (C-index: 0.927 and 0.879 for OS- and DFS-predicting, respectively). In addition, decision curves and calibration curves also revealed the great performance of the novel models. CONCLUSION: We firstly investigated the prognostic significance of preoperative radiomics signatures in ccRCC patients. Radiomics features obtained from nephrographic phase had stronger predictive ability than features from corticomedullary or unenhanced phase. Multi-omics models combining radiomics and transcriptome data could further increase the predictive accuracy.
BACKGROUND AND PURPOSE: Radiomics is an emerging field of quantitative imaging. The prognostic value of radiomics analysis in patients with localized clear cell renal cell carcinoma (ccRCC) after nephrectomy remains unknown. METHODS: Computed tomography images of 167 eligible cases were obtained from the Cancer Imaging Archive database. Radiomics features were extracted from the region of interest contoured manually for each patient. Hierarchical clustering was performed to divide patients into distinct groups. Prognostic assessments were performed by Kaplan-Meier curves, COX regression, and least absolute shrinkage and selection operator COX regression. Besides, transcriptome mRNA data were also included in the prognostic analyses. Endpoints were overall survival (OS) and disease-free survival (DFS). Concordance index (C-index), decision curve analysis and calibration curves with 1,000 bootstrapping replications were used for model's validation. RESULTS: Hierarchical clustering groups from nephrographic features and mRNA can divide patients into different prognostic groups while clustering groups from corticomedullary or unenhanced phase couldn't distinguish patients' prognosis. In multivariate analyses, 11 OS-predicting and eight DFS-predicting features were identified in nephrographic phase. Similarly, seven OS-predictors and seven DFS-predictors were confirmed in mRNA data. In contrast, limited prognostic features were found in corticomedullary (two OS-predictor and two DFS-predictors) and unenhanced phase (one OS-predictors and two DFS-predictors). Prognostic models combining both nephrographic features and mRNA showed improved C-index than any model alone (C-index: 0.927 and 0.879 for OS- and DFS-predicting, respectively). In addition, decision curves and calibration curves also revealed the great performance of the novel models. CONCLUSION: We firstly investigated the prognostic significance of preoperative radiomics signatures in ccRCC patients. Radiomics features obtained from nephrographic phase had stronger predictive ability than features from corticomedullary or unenhanced phase. Multi-omics models combining radiomics and transcriptome data could further increase the predictive accuracy.
Authors: Jean-Philippe Fortin; Drew Parker; Birkan Tunç; Takanori Watanabe; Mark A Elliott; Kosha Ruparel; David R Roalf; Theodore D Satterthwaite; Ruben C Gur; Raquel E Gur; Robert T Schultz; Ragini Verma; Russell T Shinohara Journal: Neuroimage Date: 2017-08-18 Impact factor: 6.556
Authors: Kenneth Clark; Bruce Vendt; Kirk Smith; John Freymann; Justin Kirby; Paul Koppel; Stephen Moore; Stanley Phillips; David Maffitt; Michael Pringle; Lawrence Tarbox; Fred Prior Journal: J Digit Imaging Date: 2013-12 Impact factor: 4.056
Authors: Muhammad Shafiq-Ul-Hassan; Geoffrey G Zhang; Kujtim Latifi; Ghanim Ullah; Dylan C Hunt; Yoganand Balagurunathan; Mahmoud Abrahem Abdalah; Matthew B Schabath; Dmitry G Goldgof; Dennis Mackin; Laurence Edward Court; Robert James Gillies; Eduardo Gerardo Moros Journal: Med Phys Date: 2017-03 Impact factor: 4.071
Authors: Andrea S Kierans; Henry Rusinek; Andrew Lee; Mohammed B Shaikh; Michael Triolo; William C Huang; Hersh Chandarana Journal: AJR Am J Roentgenol Date: 2014-12 Impact factor: 3.959
Authors: Meghan G Lubner; Nicholas Stabo; E Jason Abel; Alejandro Munoz Del Rio; Perry J Pickhardt Journal: AJR Am J Roentgenol Date: 2016-05-04 Impact factor: 3.959
Authors: Shih-Ying Huang; Benjamin L Franc; Roy J Harnish; Gengbo Liu; Debasis Mitra; Timothy P Copeland; Vignesh A Arasu; John Kornak; Ella F Jones; Spencer C Behr; Nola M Hylton; Elissa R Price; Laura Esserman; Youngho Seo Journal: NPJ Breast Cancer Date: 2018-08-16